Durán PEG, Paredes PJC, Rivera BC, Navarro ZJE

Idioma: Español
Referencias bibliográficas: 25
Paginas: 395-402
Archivo PDF: 174.11 Kb.

RESUMEN

La peritonitis relacionada con catéter de diálisis peritoneal es una de las complicaciones más frecuentes en los pacientes con insuficiencia renal crónica terminal en nuestro medio. Es un proceso que merece diagnóstico oportuno y tratamiento orientado al problema infeccioso y a tratar de conservar la cavidad peritoneal. Este artículo se refiere a la importancia del diagnóstico, tratamiento, complicaciones y métodos de prevención para evitar la peritonitis relacionada con diálisis peritoneal.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Vas S, Oreopoulos DG. Infections in patients undergoing peritoneal dialysis. Infect Dis Clin North Am 2001;15:743-74.

2. Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis 2003;42:1086-96.

3. Alexander JJ, Brandt CP. Vascular access and chronic ambulatory peritoneal dialysis-related infection. Prob Gen Surg 2002;19:45-52.

4. Gokal R. Peritoneal dialysis in the 21st century: an analysis of current problems and futures developments. J Am Soc Nephrol 2002;13:104-16.

5. Kavanagh D, Gordon J, Prescott, Robert A. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004;19:2584-91.

6. Broche F, Tellado JM. Defense mechanisms of the peritoneal cavity. Curr Opin Crit Care 2001;7:105-16.

7. McDonald SP. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 2004; 24:340-46.

8. Keane WF, Alexander SR, Bailie GR, Boeschoten E, et al. Peritoneal dialysis-related peritonitis treatment recomendatios. Perit Dial Int 1996;16:557-73.

9. Twardowski ZJ, Prowant BF. Current approach to exit-site infections in patients on peritoneal dialysis. Nephrol Dial Transplant 1997;12:1284-95.

10. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: A review and current concepts. Sem Dial 2003;16:428-37.

11. Alfaiw A, Vas S, Oreopoulous DG. Peritonitis in patients on automated peritoneal diálisis. Contrib Nephrol 1999;129:213-28.

12. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997:52;524-29.

13. Zelenitsky S, Barns L, Findlay I, Alfa M, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991-1998. Am J Kidney Dis 2000;36:1009-13.

14. Baños M, Cerda F, Lozano J. Microorganismo más frecuente causante de peritonitis en pacientes con insuficiencia renal crónica secundaria a nefropatía diabética, con diálisis peritoneal continua ambulatoria. Med Int Mex 2004;20:325-28.

15. Piraino B. Staphylococcus aureus infections in dialysis patients: Focus on prevention. ASAIO Journal 2000;12:S13-S17.

16. Van Westerloo DJ, Bruno MJ, Bergman JJGHM, et al. Incidence, cause and outcomes of acute pancreatitis associated with chronic peritoneal dialysis and hemodialysis. Nephrol Dial Transplant 1999;14:A235 (abstract).

17. Kane WF, Bailie GR, Boeschoten E, Gorkal R, et al. Adult peritoneal dialysis-related peritonitis teatment recommendations: 2000 update. Perit Dial Int 2000:20;396-411.

18. Mota A, Robles J. Cefepima en el tratamiento de la peritonitis concomitante con diálisis continua ambulatoria. Med Int Mex 2004;20:173-7.

19. Kleinpeter MA. Successsful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature. Adv Perit Dial 2004;20:58-61.

20. Pirano B. Peritoneal dialysis catheter replacement: “save the patient and not the catheter.” Sem Dial 2003;16:72-75.

21. Foley RN, Guo H, Snyder JJ, Gilbertson DT. Septicemia in the United Satets dialysis population. J Am Soc Nephrol 2004;15:1038-45.

22. Luzar MA, Coles GA, Faller B, Slingeneyer A, et al. Staphylococcus aureus nasal carriage and infection in patients on continuos ambulatory peritoneal dialysis. N Engl J Med 1990;322:505-9.

23. Bernardi J, Pirano B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: muperocin calcium ointment 2% applied to exit site versus cyclic oral rifampicin. Am J Kidney Dis 1996;27:695-700.

24. Strippoli GM, Tong A, Johnson D, Schena FP, Craig JC. Cathe-ter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials. J Am Soc Nephrol 2004;15:2735-46.

25. Strippoli GM, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials. Am J Kidney Dis 2004;44:591-603.